Bioengineering and Translational Medicine Impact Factor in Biotechnology

Bioengineering and Translational Medicine in Biotechnology

Journal Country: United States
Journal Q tier: Q1
Publishing Firm: John Wiley & Sons Inc.
History: 2020-2022
Journal Homepage: ----
Journal ISSN: 23806761

Research Categories

Biomedical Engineering (Q1); Biotechnology (Q1); Pharmaceutical Science (Q1)

Impact Score: 7.61
h-Index: 20
SJR: 1.484
Ranking: 2175

About Bioengineering and Translational Medicine

Bioengineering and Translational Medicine is a journal covering the technologies/fields/categories related to Biomedical Engineering (Q1); Biotechnology (Q1); Pharmaceutical Science (Q1). It is published by John Wiley & Sons Inc.. The overall rank of Bioengineering and Translational Medicine is 2175.According to SCImago Journal Rank (SJR), this journal is ranked 1.484. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 20. The best quartile for this journal is Q1.The ISSN of Bioengineering and Translational Medicine journal is 23806761.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Bioengineering and Translational Medicine is cited by a total of 685 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.